Anti-Thyroglobulin antibody [1D4] (ab16853)
- Datasheet
- References
- Protocols
Overview
-
Product nameAnti-Thyroglobulin antibody [1D4]
See all Thyroglobulin primary antibodies -
DescriptionMouse monoclonal [1D4] to Thyroglobulin
-
Host speciesMouse
-
SpecificityRecognises thyroglobulin in hyperplastic and neoplastic thyroid.
-
Tested applicationsSuitable for: IHC-Pmore details
-
Species reactivityReacts with: Human
-
Immunogen
Full length protein (Human).
-
Positive control
- Thyroid
Properties
-
FormLiquid
-
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C or -80°C. Avoid freeze / thaw cycle.
-
Storage bufferPreservative: 0.05% Sodium azide
Constituents: Tissue culture supernatant, 1% BSA -
PurityTissue culture supernatant
-
ClonalityMonoclonal
-
Clone number1D4
-
IsotypeIgG2a
-
Research areas
Associated products
-
Compatible Secondaries
Applications
Our Abpromise guarantee covers the use of ab16853 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| IHC-P |
Application notes
IHC-P: 1/25 - 1/50 in an ABC method.
Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Target
-
FunctionPrecursor of the iodinated thyroid hormones thyroxine (T4) and triiodothyronine (T3).
-
Tissue specificityThyroid gland specific.
-
Involvement in diseaseDefects in TG are the cause of congenital hypothyroidism due to dyshormonogenesis type 3 (CHDH3) [MIM:274700]. A disorder due to thyroid dyshormonogenesis, causing large goiters of elastic and soft consistency in the majority of patients. Although the degree of thyroid dysfunction varies considerably among patients with defective thyroglobulin synthesis, patients usually have a relatively high serum free triiodothyronine (T3) concentration with disproportionately low free tetraiodothyronine (T4) level. The maintenance of relatively high free T3 levels prevents profound tissue hypothyroidism except in brain and pituitary, which are dependent on T4 supply, resulting in neurologic and intellectual defects in some cases.
Variations in TG are associated with susceptibility to autoimmune thyroid disease type 3 (AITD3) [MIM:608175]. AITDs including Graves disease (GD) and Hashimoto thyroiditis (HT), are among the most common human autoimmune diseases. They are complex diseases, which are caused by an interaction between susceptibility genes and nongenetic factors, such as infection. -
Sequence similaritiesBelongs to the type-B carboxylesterase/lipase family.
Contains 11 thyroglobulin type-1 domains. -
Post-translational
modificationsSulfated tyrosines are desulfated during iodination. -
Cellular localizationSecreted.
- Information by UniProt
-
Database links
- Entrez Gene: 7038 Human
- Omim: 188450 Human
- SwissProt: P01266 Human
- Unigene: 654591 Human
-
Alternative names
- AITD 3 antibody
- AITD3 antibody
- hTG antibody
see all
Protocols
References
ab16853 has not yet been referenced specifically in any publications.
